Regeneron (REGN) Misses Q4 GAAP EPS Views on R&D, Pipeline Expansion, but EYLEA Shaping-Up Well - Roth Capital

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. MU
2. SPY
3. SPCX
4. APTX:CN
5. IQMX
6. EROC
7. MSTR
8. RIVN
9. TSLA
10. MSFT

Go back to Regeneron (REGN) Misses Q4 GAAP EPS Views on R&D, Pipeline Expansion, but EYLEA Shaping-Up Well - Roth Capital

Form 8-K REGENERON PHARMACEUTICAL For: Feb 10

February 10, 2015 7:32 AM EST


UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, DC... More